Abstract
Human-human hybridomas which secrete a human monoclonal antibody (h-MoAb) against hepatitis B virus surface antigen showed growth associated production kinetics. The rate of h-MoAb production rapidly decreased after cell growth was arrested in a perfusion culture, even if the perfusion rate was increased. A continuous suspended-perfusion culture, in which both culture broth and culture supernatant are continuously harvested and the same volume of fresh medium is continuously fed into the reactor, was developed to maintain continuous growing conditions during cultivation. In this culture system, the production of h-MoAb continued for more than 50 days with an average productivity of 5.0 mg/l of working volume/day. A semicontinuous immobilized-perfusion culture in which parts of the cells are repeatedly removed from the immobilized reactor was another useful technique for the long term cultivation of these h-h hybridomas. As an average h-MoAb production rate, 62 mg/l of immobilized-bed volume/day was achieved for 65 days of cultivation using a ceramic matrix reactor, and 327 mg/l/day was achieved over 47 days of cultivation using a hollow fiber reactor equipped with Cultureflo MTM Thus, the antibody productivity per reactor volume per day by the semicontinuous immobilized-perfusion culture was much higher than that of the continuous perfusion culture in an agitation reactor.
Similar content being viewed by others
References
Altshuler, GL, Dziewulski, DM, Sowek, JA and Belfort, G (1986) Continuous hybridoma growth and monoclonal antibody production in hollow fiber reactors-separators. Biotech. Bioeng. 28: 646–658.
Buell, DN and Fahey, JL (1969) Limited period of gene expression in immunoglobulin-synthesizing cells. Science 164: 1524–1525.
Harada, K, Ichimori, Y, Sasano, K, Sasai, S, Kitano, K, Iwasa, S, Tsukamoto, K and Sugino, Y (1989) Human-human hybridomas secreting hepatitis B virus-neutralizing antibodies. Bio/Technology 7: 374–377.
Hopkinson, J (1985) Hollow fiber cell culture systems for economical cell-product manufacturing. Bio/Technology 3: 225–230.
Ichimori, Y, Sasano, K, Itoh, H, Hitotsumachi, S, Kimura, Y, Kaneko, K, Kida, M and Tsukamoto, K (1985). Establishment of hybridomas secreting human monoclonal antibodies against tetanus toxin and hepatitis B virus antigen. Biochem. Biophys. Res. Commun. 129: 26–33.
Ichimori, Y, Harada, K, Hitotsumachi, S and Tsukamoto, K (1987). Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen. Biochem. Biophys. Res. Commun. 142: 805–812.
Kitano, K, Shintani, Y, Ichimori, Y, Tsukamoto, K, Sasai, S and Kida, M (1986). Production of human monoclonal antibodies by heterohybridomas. Appl. Microbiol. Biotechnol 24: 282–286.
Kitano, K, Iwamoto, K, Shintani, Y and Akiyama, S (1988). Effective production of a human monoclonal antibody against tetanus toxoid by selection of high productivity clones of a heterohybridoma. J. Immunol. Methods 109: 9–16.
Kitano K, Iwamoto K, Shintani Y and Sasada R (1990). Improvement in cell lines for effective production of human monoclonal antibodies by human-human hybridomas. Proceeding of the 2nd annual meeting of Japanese Association for Animal Cell Technology (JAACT '89) in press.
Knazek, RA, Gullino, PM, Kohler, PO and Dedrick, RL (1972) Cell culture on artificial capillaries: an approach to tissue growthin vitro. Science 178: 65–67.
Kwong, CW, Hsieh, JH, Syu, MJ and Chou, SS (1989). Antihepatitis B surface antigen monoclonal antibody IgM production in suspension and immobilized cell bioreactors. Biotechnology Letters 2: 377–382
Lydersen, BK, Pugh, GG, Paris, MS, Sharma, BP and Noll, LA (1985). Ceramic matrix for large scale animal cell culture. Bio/Technology 3: 63–67.
Merten, OW (1987). Concentrating mammalian cells: 1. largescale animal cell culture. Trends Biotechnol. 5: 230–237.
Merten, OW (1988). Batch production and growth kinetics of hybridomas. Cytotechnology 1: 113–121.
Murata, M, Eto, Y and Shibai, H (1988). Large-scale production of erythroid differantiation factor(EDF) by gene engineering chinese hamster ovary (CHO) cells in suspension culture. J. Ferment. Technol. 66: 501–507.
Ray, NG, Karkare, SB and Runstadler, PW (1989). Cultivation of hybridoma cells in continuous cultures: Kinetics of growth and product formation. Biotechnol. Bioeng. 33: 724–730.
Reuveny, S, Velex, D, Miller, L and Macmillan, JD (1986). Comparison of cell propagation methods for their effect on monoclonal antibodies yield in fermenters. J. Immunol. Method. 86: 61–69.
Shintani, Y, Iwamoto, K and Kitano, K (1988). Polyethylene glycols for promoting the growth of mammalian cells. Appl. Microbiol. Biotechnol. 27: 533–537.
Suzuki, E and Ollis, DF (1989). Cell cycle model for antibody production kinetics. Biotechnol. Bioeng. 34: 1398–1402.
Takazawa, Y, Tokashiki, M, Hamamoto, K and Murakami, H (1988). High cell density perfusion culture of hybridoma cells recycling high molecular weight components. Cytotechnology 1: 171–175.
Takazawa, Y and Tokashiki, M (1989). Production of human-mouse chimeric antibody by high cell density perfusion culture. Cytotechnology 2: 95–101.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shintani, Y., Kohno, YI., Sawada, H. et al. Comparison of culture methods for human-human hybridomas secreting anti-HBsAg human monoclonal antibodies. Cytotechnology 6, 197–208 (1991). https://doi.org/10.1007/BF00624758
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00624758